India to Brazil: Axitinib Export Trade Route
India has recorded 13 verified shipments of Axitinib exported to Brazil, representing a combined trade value of $9.7K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $750 USD. The leading Indian exporter is SPECIALITY MEDICINES LIMITED, which accounts for 75% of total export value with 1 shipments worth $7.3K USD. On the buying side, TO THE ORDER OF is the largest importer in Brazil with $9.3K USD in purchases. The top 3 suppliers — SPECIALITY MEDICINES LIMITED, GLOBYZ BIOPHARMA PRIVATE LIMITED, ALLEVIARE LIFE SCIENCES PRIVATE LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Axitinib corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $9.7K USD. The route is dominated by SPECIALITY MEDICINES LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's axitinib manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $750 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with axitinib's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 27.5%, placing it at rank #19 among India's top axitinib export destinations globally.
On the import side, key buyers of Indian axitinib in Brazil include TO THE ORDER OF, CELIO MATIAS, ANANIAS LIMA and 2 others. TO THE ORDER OF is the single largest importer with 2 shipments valued at $9.3K USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ3
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#19
- Annual growth+27.5%
- Demand growth+24.9%
- Regulatory ease80/100
Top 10 Indian Axitinib Exporters to Brazil
Showing top 10 of 5 Indian suppliers exporting Axitinib to Brazil, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SPECIALITY MEDICINES LIMITED Avg $7.3K per shipment | 1 | $7.3K | 75.0% |
| 2 | GLOBYZ BIOPHARMA PRIVATE LIMITED Avg $2.0K per shipment | 1 | $2.0K | 20.3% |
| 3 | ALLEVIARE LIFE SCIENCES PRIVATE LIMITED Avg $158 per shipment | 2 | $316 | 3.2% |
| 4 | JPC GLOBAL Avg $136 per shipment | 1 | $136 | 1.4% |
| 5 | DR.REDDY'S LABORATORIES LIMITED Avg $1 per shipment | 8 | $7 | 0.1% |
This table shows the top 10 of 5 Indian companies exporting axitinib to Brazil, ranked by total trade value. The listed exporters are: SPECIALITY MEDICINES LIMITED, GLOBYZ BIOPHARMA PRIVATE LIMITED, ALLEVIARE LIFE SCIENCES PRIVATE LIMITED, JPC GLOBAL, DR.REDDY'S LABORATORIES LIMITED. SPECIALITY MEDICINES LIMITED is the dominant supplier with 1 shipments worth $7.3K USD, giving it a 75% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Top 10 Axitinib Importers in Brazil
Showing top 10 of 5 known buyers in Brazil receiving Axitinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian axitinib in Brazil include TO THE ORDER OF, CELIO MATIAS, ANANIAS LIMA, ANTONIO MAX STERPELONI, DR. REDDYS FARMACEUTICA DO BRASIL. The largest importer is TO THE ORDER OF, accounting for $9.3K USD across 2 shipments — representing 95% of all axitinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER OF | 2 | $9.3K | 95.3% |
| 2 | CELIO MATIAS | 1 | $219 | 2.2% |
| 3 | ANANIAS LIMA | 1 | $136 | 1.4% |
| 4 | ANTONIO MAX STERPELONI | 1 | $98 | 1.0% |
| 5 | DR. REDDYS FARMACEUTICA DO BRASIL | 8 | $7 | 0.1% |
Top 10 Axitinib Formulations Imported by Brazil
Showing top 10 of 13 product formulations shipped on the India to Brazil Axitinib route, ranked by trade value
Brazil imports a wide range of axitinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE AXITINIB TABLETS 5 MG BATCH NO.HT1019 — accounts for $7.3K USD across 1 shipments. There are 13 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE AXITINIB TABLETS 5 MG BATCH NO.HT1019 | 1 | $7.3K | 75.0% |
| 2 | AXITINIB TABLETS Product Name: INLYTA 5MG Manufacturer: PFIZER Pack Size: 1 STRIPS OF 14 TABLETS EACH(AS PER INVOICE) | 1 | $2.0K | 20.3% |
| 3 | PHARMACEUTICAL PRODUCT EACH TABLET OF AXITINIB 1MG AXPERO 1 TABLETS | 1 | $219 | 2.2% |
| 4 | HARMLESS PHARMACEUTICAL FINISHED PRODUCT- AXITINIB 5MG TABSPCS | 1 | $136 | 1.4% |
| 5 | PHARMACEUTICAL PRODUCT EACH TABLET OF AXITINIB 1MG AXPERO 1MG TABLET B.NO-POV24089A,MFG.DT-10/2024,EXP.DT-09/2026=4PACKS | 1 | $98 | 1.0% |
| 6 | PLACEBO FOR AXITINIB TABLETS 1 MG | 1 | $1 | 0.0% |
| 7 | PLACEBO FOR AXITINIB TABLETS 5 MG | 1 | $1 | 0.0% |
| 8 | PLACEBO FOR AXITINIB TABLETS 1 MG125GMS1 | 1 | $1 | 0.0% |
| 9 | PLACEBO FOR AXITINIB TABLETS 5 MG125GMS1 | 1 | $1 | 0.0% |
| 10 | AXITINIB TABLETS 5 MG | 1 | $0 | 0.0% |
Showing top 10 of 13 Axitinib formulations imported by Brazil on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 8 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's axitinib exports to Brazil are driven primarily by a handful of large-scale manufacturers. SPECIALITY MEDICINES LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SPECIALITY MEDICINES LIMITED, GLOBYZ BIOPHARMA PRIVATE LIMITED, ALLEVIARE LIFE SCIENCES PRIVATE LIMITED — together account for 99% of total trade value on this route. The average shipment value of $750 USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as axitinib tablets product name: inlyta 5mg manufacturer: pfizer pack size: 1 strips of 14 tablets each(as per invoice) and pharmaceutical product each tablet of axitinib 1mg axpero 1 tablets, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER OF is the largest importer with 2 shipments worth $9.3K USD — representing 95% of all axitinib imports from India on this route.
Route Statistics
- Trade Volume
- $9.7K
- Avg. Shipment
- $750
- Suppliers
- 5
- Buyers
- 5
- Transit (Sea)
- ~22 days
- Annual Growth
- +27.5%
Reverse Direction
Brazil → India — Axitinib (Import)Other Axitinib Routes
Unlock the Full India to Brazil Axitinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 13 shipments on this route.
Frequently Asked Questions — India to Brazil Axitinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Axitinib to Brazil?
The leading Indian exporters of Axitinib to Brazil are SPECIALITY MEDICINES LIMITED, GLOBYZ BIOPHARMA PRIVATE LIMITED, ALLEVIARE LIFE SCIENCES PRIVATE LIMITED. SPECIALITY MEDICINES LIMITED holds the largest market share at approximately 75% of total trade value on this route.
Q What is the total value of Axitinib exports from India to Brazil?
India exports Axitinib to Brazil worth approximately $9.7K USD across 13 recorded shipments. The average value per shipment is $750 USD.
Q Which ports does India use to ship Axitinib to Brazil?
The most active port of origin is HYDERABAD AIR with 8 shipments. Indian exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Brazil for Axitinib?
The average transit time for Axitinib shipments from India to Brazil is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Brazil Axitinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.5% with demand growth tracking at 24.9%. The route is ranked #19 among India's top Axitinib export destinations globally.
Q How many suppliers are active on the India to Brazil Axitinib route?
There are currently 5 active Indian suppliers exporting Axitinib to Brazil. The market is moderately concentrated with SPECIALITY MEDICINES LIMITED accounting for 75% of total shipment value.
Q Who are the main importers of Axitinib from India in Brazil?
The leading importers of Indian Axitinib in Brazil include TO THE ORDER OF, CELIO MATIAS, ANANIAS LIMA, ANTONIO MAX STERPELONI, DR. REDDYS FARMACEUTICA DO BRASIL. TO THE ORDER OF is the largest buyer with 2 shipments worth $9.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Brazil export trade corridor identified from Indian Customs (DGFT) records for Axitinib.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 5 importers in Brazil matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 13 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists